DR. LAUTE MARGO, NEFROLOGIE
0688.782.053 · rovalta.com · 26/09/2026
DR. LAUTE MARGO, NEFROLOGIE
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBODR. LAUTE MARGO, NEFROLOGIE is a Private limited company incorporated in 2018. Its registered office is in Gent.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0688.782.053
- Incorporation
- 23/01/2018
- Legal form
- Private limited company
- Registered office
- Beekstraat 35
9031 Gent · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/09/2025
Financials
Source · NBB, 9 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 453 k € | -2.6% | 465,3 k € | +38.3% | 336,3 k € | +49.4% | 225,2 k € | +19.5% | 188,4 k € |
| EBITDA | 452,3 k € | -2.6% | 464,6 k € | +38.3% | 336,1 k € | +50.0% | 224,1 k € | +19.6% | 187,4 k € |
| Operating result | 420,7 k € | -2.6% | 432,1 k € | +42.1% | 304,1 k € | +59.2% | 191 k € | +23.0% | 155,3 k € |
| Net result | 317,8 k € | -4.0% | 330,9 k € | +44.6% | 228,9 k € | +58.8% | 144,2 k € | +22.4% | 117,8 k € |
| Balance sheet | |||||||||
| Equity | 18,6 k € | 0.0% | 18,6 k € | -84.5% | 119,8 k € | +193% | 40,9 k € | -79.2% | 196,8 k € |
| Total assets | 417,9 k € | -17.1% | 504,2 k € | +11.1% | 453,9 k € | -15.1% | 534,4 k € | -17.4% | 646,8 k € |
| Cash | 339 k € | -16.8% | 407,3 k € | +25.3% | 325,1 k € | -14.7% | 381,1 k € | -16.5% | 456,3 k € |
| Debts | 399,1 k € | -17.8% | 485,6 k € | +45.4% | 334 k € | -32.2% | 492,6 k € | +9.5% | 450 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20251 active · 3 ended
Active mandates
Ended mandates
Other companies at this address
Beekstraat 35 9031 Gent| Company | CBE no. |
|---|---|
| 0760.917.191 | |
DR. PIET OST, RADIOTHERAPIE● Active | 0761.430.796 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/12/2025 | 28/02/2025 | 30/01/2024 | 02/05/2023 | 06/04/2022 | 06/04/2021 |
| General meeting | 22/12/2025 | 25/02/2025 | 29/01/2024 | 30/03/2023 | 31/03/2022 | 25/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2025 | 22/12/2025 | 23/12/2025 | Dutch | |
| Micro model | 30/09/2024 | 25/02/2025 | 28/02/2025 | Dutch | |
| Micro model | 30/09/2023 | 29/01/2024 | 30/01/2024 | Dutch | |
| Micro modelCorrection | 30/09/2022 | 30/03/2023 | 02/05/2023 | Dutch | |
| Micro model | 30/09/2022 | 30/03/2023 | 31/03/2023 | Dutch | |
| Micro model | 30/09/2021 | 31/03/2022 | 06/04/2022 | Dutch | |
| Micro model | 30/09/2020 | 25/03/2021 | 06/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 26/03/2020 | 27/03/2020 | Dutch | |
| Micro model | 30/09/2018 | 28/03/2019 | 24/04/2019 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025317,8 k €↓
- 2024Annual accounts 2024330,9 k €↑
- 2023Annual accounts 2023228,9 k €↑
- 2022Annual accounts 2022144,2 k €↑
- 2021Annual accounts 2021117,8 k €↑
- 2019Annual accounts 2019117,5 k €↑
- 2018Annual accounts 201862,9 k €
- 23/01/2018IncorporationPrivate limited company